Azenta, Inc. $AZTA Shares Sold by Royal Bank of Canada

Royal Bank of Canada decreased its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 5.2% in the 1st quarter, HoldingsChannel.com reports. The firm owned 494,469 shares of the company’s stock after selling 27,260 shares during the period. Royal Bank of Canada’s holdings in Azenta were worth $10,449,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in AZTA. Caitong International Asset Management Co. Ltd raised its holdings in shares of Azenta by 2,067.6% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 802 shares of the company’s stock worth $27,000 after purchasing an additional 765 shares in the last quarter. Assetmark Inc. grew its position in Azenta by 54.1% in the fourth quarter. Assetmark Inc. now owns 832 shares of the company’s stock worth $28,000 after buying an additional 292 shares during the last quarter. State of Wyoming acquired a new position in Azenta in the first quarter worth approximately $38,000. Osaic Holdings Inc. increased its holdings in shares of Azenta by 44.9% in the second quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock valued at $39,000 after buying an additional 385 shares in the last quarter. Finally, Rockefeller Capital Management L.P. lifted its position in shares of Azenta by 98.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company’s stock valued at $46,000 after acquiring an additional 689 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Wall Street Analyst Weigh In

AZTA has been the subject of several research reports. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 15th. Needham & Company LLC boosted their target price on Azenta from $33.00 to $37.00 and gave the stock a “buy” rating in a research report on Wednesday. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Azenta presently has an average rating of “Hold” and an average price target of $41.20.

Azenta Trading Up 4.2%

Shares of Azenta stock opened at $32.04 on Friday. Azenta, Inc. has a 1 year low of $15.93 and a 1 year high of $41.73. The company has a market cap of $1.48 billion, a P/E ratio of -11.61 and a beta of 1.37. The stock has a 50-day moving average price of $25.62 and a 200 day moving average price of $25.53.

Azenta (NASDAQ:AZTA) last issued its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $161.18 million for the quarter, compared to the consensus estimate of $149.31 million. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%.

Azenta Profile

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.